Table 4.
Predictors of Diastolic Dysfunction
Stage ≥ 1 (Model R2 = 0.24) | Mean e′ (Model R2 = 0.27) | Mean E/e′ (Model R2 = 0.14) | ||||
---|---|---|---|---|---|---|
β (SE) | p | β (SE) | p | β (SE) | p | |
10 year Framingham Risk Score (*) | 0.07 (0.04) | 0.09 | −0.11 (0.04) | 0.01 | 0.02 (0.04) | 0.59 |
Metabolic Syndrome | −0.01 (0.46) | 0.98 | −0.07 (0.54) | 0.90 | 0.59 (0.54) | 0.28 |
Subclinical Coronary Artery Disease | −0.11 (0.58) | 0.84 | −0.36 (0.69) | 0.60 | −0.03 (0.69) | 0.96 |
Left Ventricular Mass Index | 0.009 (0.01) | 0.41 | 0.005 (0.01) | 0.70 | −0.006 (0.01) | 0.63 |
Epicardial Fat Volume Index | 0.03 (0.01) | 0.01 | −0.02 (0.006) | <0.0001 | 0.04 (0.01) | 0.001 |
Values in table are nonstandardized correlation coefficient (B) with standard error (SE) and p values after adjusting for all the covariates listed.
Framingham Risk Score included: age, gender, systolic blood pressure, total cholesterol, high density lipoprotein, smoking status. LVMI stands for left ventricular mass index, EFV – epicardial fat volume index.